TGEN Tecogen Inc

Targeted Genetics Corporation (NASDAQ:TGEN) will report its fourth quarter and year-ended 2005 financial results on Thursday, March 9, 2006, before the open of the financial markets. Following the announcement, management will host a conference call and webcast discussion of the financial results and provide a general corporate update beginning at 10:30 a.m. EST (7:30 a.m. PST). The Webcast will be available at http://www.targetedgenetics.com in the "upcoming events" section of the homepage. You may also access the 24-hour telephone replay approximately one hour post the end of the live teleconference by calling 800.405.2236 (domestic) or 303.590.3000 (international), and entering passcode: 11052769#. About Targeted Genetics Targeted Genetics Corporation is a biotechnology company committed to the development and commercialization of innovative targeted molecular therapies for the prevention and treatment of inflammatory arthritis, HIV/AIDS and other acquired and inherited diseases with significant unmet medical need. Targeted Genetics uses its considerable knowledge and capabilities in the development and manufacturing of gene delivery technologies to advance a diverse product development pipeline. Its product development efforts target inflammatory arthritis, HIV/AIDS, congestive heart failure, Huntington's disease, and hyperlipidemia. To learn more about Targeted Genetics, visit its website at www.targetedgenetics.com.